Suven Life Sciences Ltd.

NSE : SUVEN

Add Alert

Add Watchlist

₹231.2

-4.0 (-1.7%) - 18 Aug 2025 04:31 PM

NSE : SUVEN

About Company

Suven Life Sciences provides wide range of Drug Discovery and Development Support Services (DDDSS) to global Pharma and Biotech companies. Suven has state-of-art facilities with highly qualified & experienced team of scientists. Suven offer research services specializing in Synthetic, Medicinal and Analytical Chemistry, In-vitro Assay development and Screening, Drug Metabolism & Pharmacokinetics, CNS Pharmacology (Behavioral Pharmacology, Microdialysis, Receptor Occupancy, Electrophysiology), Toxicology and Safety Pharmacology, Bioanalysis, and NCE Formulations.

Market Cap. ₹ 5,259 Cr.

52 Week - High/Low ₹ 300/102

P/E Ratio

P/B Ratio 6.58

Enterprise Value ₹ 5,241 Cr.

ROE % -5.73

RSI Value 31.24

EMA 50 248.09

EMA 200 185.71

Market Cap. ₹ 5,259 Cr.

52 Week - High/Low ₹ 300/102

P/E Ratio